Sagimet Biosciences Inc.
- SGMT
- NASDAQ
- Biotechnology
- FASN Inhibitors
- Metabolic/Fibrotic Disease Therapeutics
$8.02
Today −1.84%Quote Oct 16, 2026, 08:00 PM UTC
−28.20%over the last month
Max drawdown −32.4%From 1-month high −28.2%3 months +12.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$426.0M
Approximate share count
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$20.00
+149.4% from here
Floor
$7.79
2.8% below price
Where the price sits
9 analysts
Analyst range, low to high
$7.00$29.00
- Price $8.02
- Resistance $8.10
- Consensus $20.00
The price is right under resistance. Analysts' average target sits about 149% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SGMTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
16
Founded
2006